COMMUNIQUÉS West-GlobeNewswire

Alphatec to Report First Quarter 2019 Financial Results on May 9, 2019
18/04/2019
CARLSBAD, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq: ATEC) (“Alphatec” or the “Company”), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to [...]
Meridian Launches a New Inhibitor Tolerant qPCR Reagent to Significantly Simplify Molecular Diagnostic Workflows From Crude Samples
18/04/2019
CINCINNATI, April 18, 2019 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced the launch of its Inhibitor-tolerant qPCR Mix, a novel mix to accelerate workflows and improve DNA target [...]
Precision Therapeutics’ Subsidiary Helomics and National Alopecia Areata Foundation Sign Services Agreement to Provide Next-Generation Patient Registry for Alopecia Areata Research
18/04/2019
MINNEAPOLIS and SAN RAFAEL, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced a services agreement between its wholly owned subsidiary, [...]
Mr. Ori Karev Joins Precipio Executive Team As Chief Strategy Officer
18/04/2019
Precipio to expand its reach globally NEW HAVEN, Conn., April 18, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) announced today that Mr. Ori Karev has joined the company as its [...]
Marrone Bio Innovations addresses increasing threats to almonds with two biological insecticides
18/04/2019
Venerate® XC and Grandevo® WDG are proven to minimize damage from navel orangeworm and other pests, driving improved crop yields and quality while empowering growers to meet California’s Almond Orchard 2025 Goals DAVIS [...]
MedTainer – Late Annual Report on Form 10-K
18/04/2019
CORONA, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- MedTainer, Inc. (MDTR-OTCMARKETS) announced today that it has not filed its Annual Report on Form 10-K with the Securities and Exchange Commission on time, but expects [...]
PSIQ Announces CBD Flower Added to Product Line, Creating Substantial Revenue Opportunity
18/04/2019
SUNRISE, Fla., April 18, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc. (“Elite”), has added CBD Flower to its [...]
IMMUNOTHERAPY COMPANY ENLIVEX THERAPEUTICS SELECTED TO RECEIVE AN ADDITIONAL $1 MILLION GRANT BY THE ISRAEL INNOVATION AUTHORITY FOR ITS SEPSIS CLINICAL PROGRAM
18/04/2019
Nes Ziona, Israel, April 18, 2019 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (Nasdaq: ENLV), a clinical-stage immunotherapy company, today announced that the Israel Innovation Authority (IIA) selected the Company’s [...]
Fulgent Genetics to Announce First Quarter 2019 Financial Results on Tuesday May 7, 2019
18/04/2019
TEMPLE CITY, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its first quarter 2019 financial results after the [...]
Momenta Pharmaceuticals Announces Date of First Quarter 2019 Financial Results Conference Call and Webcast
18/04/2019
CAMBRIDGE, Mass., April 18, 2019 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated [...]
Progressive Care Inc. Garners Coverage in MedTruth
18/04/2019
MIAMI, April 18, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that it has garnered media coverage in MedTruth in an article [...]
Ovid Therapeutics to Present at the American Academy of Neurology 71st Annual Meeting
18/04/2019
Emerging Science platform presentation highlights efficacy and safety data of OV101 in Angelman syndrome from the STARS study Research from Ovid’s Fragile X program shows new insights for outcome assessments NEW YORK, [...]
Resverlogix’ BETonMACE Phase 3 Trial Successfully Reaches its Targeted 250 MACE Events
18/04/2019
World’s First Phase 3 BET Bromodomain Epigenetics Trial Reaches Events Target CALGARY, Alberta, April 18, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX:RVX) today announces that [...]
Geron Expands Senior Leadership of Its Development Team
18/04/2019
MENLO PARK, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today announced an expansion of its development team’s senior leadership with the addition of three highly experienced [...]
RTI Surgical® Schedules First Quarter 2019 Earnings Call for May 2, 2019
18/04/2019
DEERFIELD, Ill., April 18, 2019 (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant company, today announced it plans to release financial results from the first quarter 2019 on [...]
ICU Medical, Inc. Announces Time of First Quarter 2019 Earnings Conference Call
18/04/2019
SAN CLEMENTE, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care [...]
Harpoon Therapeutics Doses First Patient with a Mesothelin-Targeting T cell Engager (HPN536) in Phase 1/2a Clinical Trial for Ovarian and Other Solid Tumor Cancers
18/04/2019
HPN536 is the second TriTAC T cell engager to enter clinical development from the Harpoon pipeline Trial initiated at Sarah Cannon Research Institute in Nashville, Tenn. - a leading drug development organization SOUTH [...]
Robust Analgesic Activity of Aptinyx’s NYX-2925 in Advanced DPN Patients Revealed Through Further Analysis of Data from Phase 2 Study
18/04/2019
M echanism of NYX-2925 is highly relevant in advanced DPN patients with longer duration of chronic pain Results support and inform future Phase 2 study, initiation expected in 2019 EVANSTON, Ill., April 18, 2019 (GLOBE [...]
Emergent BioSolutions to Release First Quarter 2019 Financial Results and Conduct a Conference Call on May 2, 2019
18/04/2019
GAITHERSBURG, Md., April 18, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, May 2, 2019 at 5:00 pm (Eastern Time) to discuss the financial results for the first [...]

Pages